| PERIOD ENDING | 27-Aug-09 | 28-May-09 | 26-Feb-09 | 27-Nov-08 | | Total Revenue | 110,153 | 84,171 | 91,011 | 87,943 | | Cost of Revenue | 57,036 | 71,268 | 51,458 | 44,541 | | | Gross Profit | 53,117 | 12,903 | 39,553 | 43,402 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,054 | (134) | 25,432 | 26,896 | | Non Recurring |
-
| 212 | 27 | 16 | | Others | 8,088 | 7,893 | 7,916 | 8,148 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,975 | 4,932 | 6,178 | 8,342 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 111 | 938 | 295 | (3,120) | | Earnings Before Interest And Taxes | 19,055 | 5,817 | 6,149 | 5,207 | | Interest Expense | 2,972 | 3,070 | 3,455 | 3,641 | | Income Before Tax | 16,083 | 2,747 | 2,694 | 1,566 | | Income Tax Expense | 5,865 | 539 | 1,031 | 670 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,218 | 2,208 | 1,663 | 896 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,218 | 2,208 | 1,663 | 896 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,218 | $2,208 | $1,663 | $896 |
|
0.51% Nasdaq 
Income Statement
